A recent population study in the United States has described four molecular breast cancer subtypes as mentioned above, based on the expression of three tumor markers, namely estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) (5, 6). This evidence concerns the gene ESR1 and breast cancer.